Evidence mapPaperPMID 41928358Full record

ArticleLaboratory animal research2026

Chronic kidney disease induces a distinct lipidomic signature and accelerates atherosclerosis progression in a novel minipig model.

Marcelino Bermúdez-López, Paula Nogales, Manuel Martí-Antonio, Eva Castro-Boqué, Virtudes M de Lamo, Laia Beà-Menchón, Sergio Luis-Lima, Esteban Porrini, Xavier Sanchez-Salguero, Mariona Jové and 12 more

Abstract read
In one paragraph

Article in Laboratory animal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Marcelino Bermúdez-LópezDepartment of Experimental Medicine, University of Lleida (UdL), Lleida, Spain. mbermudez@irblleida.cat.
Paula NogalesCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Manuel Martí-AntonioVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Eva Castro-BoquéVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Virtudes M de LamoVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Laia Beà-MenchónVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Sergio Luis-LimaDepartment of Laboratory Medicine, Complejo Hospitalario Universitario de Canarias, Santa Cruz de Tenerife, Spain.
Esteban PorriniInstituto Tecnologías Biomédicas, University of La Laguna, Tenerife, Spain.
Xavier Sanchez-SalgueroDepartment of Animal Science, ETSEAFIV, University of Lleida, Lleida, Spain.
Mariona JovéDepartment of Experimental Medicine, University of Lleida (UdL), Lleida, Spain.
Elia ObisDepartment of Experimental Medicine, University of Lleida (UdL), Lleida, Spain.
Natàlia Mota-MartorellDepartment of Experimental Medicine, University of Lleida (UdL), Lleida, Spain.
Aurora Pérez-GómezVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Alicia Garcia-CarrascoVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Milica BozicVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Jesús GuajardoVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain.
Carlos J Pérez-SánchezBiostatistics Unit, Faculty of Veterinary Medicine, University of Extremadura, Cáceres, Spain.
Serafí CambrayBasic Medical Sciences Department, Serra Hunter Lecturer, University of Lleida (UdL), Lleida, Spain.
Núria AmigóBiosfer Teslab, Reus, Spain. Department of Basic Medical Sciences, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Reinald PamplonaDepartment of Experimental Medicine, University of Lleida (UdL), Lleida, Spain.
Jacob F BentzonCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
José M ValdivielsoVascular and Renal Translational Research Group, Institute for Research in Biomedicine of Lleida (IRBLleida), RICORS2040, Madrid, Lleida, Spain. josemanuel.valdivielso@udl.cat.ORCID http://orcid.org/0000-0003-1343-0184

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) markedly accelerates atherosclerosis, driving the excess cardiovascular morbidity and mortality in these patients. While rodent models have been indispensable for mechanistic studies, their small vessel size limits the use of non-invasive vascular imaging to monitor disease progression. Therefore, large-animal models are needed to bridge experimental insights with clinical applicability. We aimed to establish a novel minipig model of CKD to characterize the temporal changes of CKD-driven atherosclerosis. Six female Yucatan minipigs overexpressing a human gain-of-function PCSK9 mutant were randomized to CKD (n = 3) or control (n = 3) groups. CKD was induced by selective clamping of the left renal artery branches combined with contralateral nephrectomy using a minimally invasive laparoscopic approach. All animals were fed with a high-fat, high-cholesterol diet and followed for 15 months. Longitudinal assessments included vascular and renal ultrasound, computed tomography, plasma iohexol clearance for glomerular filtration rate (GFR) determination, and biochemical profiling of ions, cytokines, chemokines, and lipids, including advanced lipoprotein, lipidomic and fatty acid analyses. Between-groups differences were evaluated using effect sizes with 95% confidence intervals.

resultsCKD pigs exhibited a significant reduction in GFR and increased blood creatinine. They exhibited accelerated atherogenesis, reflected by enhanced progressive adventitial vasa vasorum neovascularization in both carotid and iliac arteries, a higher burden of arterial calcifications in abdominal aorta and iliac arteries and postmortem larger atherosclerotic plaques and calcified areas in coronary arteries. CKD also altered the systemic inflammation profile (elevated IL-1ra, IL-2, IL-4, IL-8, and IL-10), promoted a proatherogenic lipoprotein phenotype with triglyceride-enriched VLDL, LDL, and IDL particles, increased VLDL particle number, and reduced LDL particle size. Lipidomic analyses revealed increased circulating and renal palmitic acid and distinct lesion-specific fatty acid signatures. Fatty streaks were enriched in palmitic acid and 10,16-dihydroxy-palmitic acid, and mature carotid plaques accumulated polyunsaturated fatty acids.

conclusionsThis minimally invasive CKD model in gentically modified minipigs accelerates atherosclerosis and induces a unique lipidomic remodelling, providing a valuable translational platform to study kidney-vascular interactions and to test therapeutic interventions targeting CKD-driven atherosclerosis.

Indexed as

AtherosclerosisCKDContrast-enhanced ultrasoundPalmitic acidPigSwineUntargeted lipidomicsVasa vasorum

Identifiers

PMID41928358
PMCPMC13045143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.